knowledge -WSS

knowledge

author：hotspot 2025-09-29 21:24:17 - browse：2

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： How CRISPR works, explained in two minutes

WSS

Doctors are clamoring for more clarity on Paxlovid prescribing

St. Louis police protesters begin picking up checks in $4.9 million settlement

Tuberculosis patients need more than just free medication

Flash flood warnings continue for parts of Missouri, Illinois

Many breast cancer patients receive more radiation than needed

It was time to plan for my old age. If only I could stop crying

hotspot

knowledge

Wikipedia

The high cost of giving birth even with insurance

'Brian's Song' at 50 still offers lessons about cancer for today

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Tuberculosis patients need more than just free medication

FDA approval of Sarepta Duchenne genetic therapy gives me hope

It was time to plan for my old age. If only I could stop crying

How to save PrEP access — and even expand it

Restaurant meals are packed with calories, and we still keep eating them

Medical records are filled with copy

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

explore

Many breast cancer patients receive more radiation than needed

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

How CRISPR works, explained in two minutes

Restaurant meals are packed with calories, and we still keep eating them

It was time to plan for my old age. If only I could stop crying

Doctors are clamoring for more clarity on Paxlovid prescribing

knowledge

knowledge

focus

hotspot